Investment with impact. Rise Health Venture Capital (RISE) delivers on that promise by investing in the untapped talent among founders and owners with minimal access to an equitable distribution of healthcare startup funding and resources, specifically in the oral health space.
Real inclusion, strength and empowerment for untapped talent and underserved businesses in the oral health space, including, but not limited to, women-, LBGTQ+- and minority-owned businesses.
Rise Health is built on decades of experience and a track record of backing high performing founders. We leverage medical and business breakthroughs as well as emerging technologies to improve the oral health and overall healthcare systems.
By leveling the playing field of access to startup capital at competitive terms, RISE can bring many quality products and companies to the next level, most of which may otherwise not be given the opportunity to fully benefit our healthcare systems.
As dentists and well-connected business professionals, specifically in the DSO industry, we have unique access to modern ideas with a complete understanding of the market and how to implement products within it. We know where service and product gaps lie and how new ideas and products will be received. Further, Revere Partners, our partner and first VC fund on oral health, has a longstanding track record of successful investments and exits.
Since before the pandemic, RISE’s founding team has been hard at work on this platform, assembling the key pieces to build a sustainable fund approach. As such, we have access to:
In 2018, 32% of dentists were women and 28% were racial/ethnic minorities. In 2008, 23% were women and 22% were minorities.
RISE fills a gap for groups that lack funding and lack of proper valuation for their business in the oral health space.
Offer investors a platform to diversify their startup portfolios and provide much needed capital to health and oral health founders with limited access and untapped potential.
Investor exposure is heavily concentrated in male dominated tech and consumer products.
Management and ownership are homogenous, lacking thought inclusion.
Innovation in the dental industry is hindered by less-than-ideal capital flow.
Providers focused on the clinical aspects of their practices lack time or resources to maximize business opportunities.
Our data is acquired from over 600 real companies and combined with conservative assumptions from experts in investing, acquiring, and operating companies across all facets of the oral care industry.
The combination of strong returns and historical under-investment make for a profitable opportunity investing in dental startups.
Male % vs. Female %
Male % vs. Female %
Male % vs. Female % Ownership
X
Male Founded Companies vs. Female Founded Companies
Dental remains a small piece of the pie and is under-invested in, relative to its market size.
Our research shows early stage companies offer a higher risk to return ratio relative to other common dental industry investment strategies.
While early stage companies are often seen as riskier investments, our research shows they offer a higher risk to return ratio relative to other common dental industry investment strategies.
Real inclusion, strength and empowerment for untapped talent and underserved businesses in the oral health space, including, but not limited to, women-, LBGTQ+- and minority-owned businesses.
Real inclusion, strength and empowerment for untapped talent and underserved businesses in the oral health space, including, but not limited to, women, LBGTQ+- and minority-owned businesses.
Dr. Jeremy Krell, MBA, is a general dentist, as well as an experienced investor with a business background. He has raised rounds and generated returns for investors at ten companies, sold three, and acquired two more as a key operator. Jeremy oversaw strategic provider innovation and development at Oscar Health, a health insurance company that had an IPO in 2021. He also led provider and clinical growth initiatives at quip, a subscription oral health company, and has since built the Barchester Bay Group, a portfolio consisting of over thirty separate ventures. Jeremy is an angel investor and sits on the boards of several healthcare and dental startups. He has a fifteen-plus year proven track record with start-ups, multi-million dollar fundraises, and acquisitions.
Dr. Aman Kaur, MBA, a DSO industry veteran, and a seasoned executive is known for her passion for building DSO organizations ground up and doing turn-arounds through innately inspired teams and driving results. Dr. Kaur is the Founder and President for Women In DSO, an organization committed to providing industry defining platform to promote and advance women leaders across the DSO industry. Dr. Kaur is also working as the CEO of a rapidly growing Midwest based DSO. With over 18years of experience in Dental industry, Dr. Kaur has worked with multiple DSOs over her career in various leadership roles and is very involved in DSO industry as a Board member of DSOs, Government Dental Programs and Dental Product Companies. Dr. Kaur is passionate about improving the access to dental care and believes this needs growing services in dental sector that encompass overall health needs along with supporting dental teams to continually grow as clinicians as well as the leaders. Respected as a credible voice in industry for her clinical and business decision-making, finding strategic solutions and building partnerships and alliances across the industry, Dr. Kaur is constantly shaping the industry.
David Arena is an experienced investor, technologist, and finance professional. He spent a decade advising institutional clients on investment strategy and developing systematic trading strategies at the world’s largest hedge fund. Now he applies his analytical skill-set on leadership teams at numerous startups, managing capital raises, operations strategy, and growth initiatives. He most recently served as CFO and CTO at an oral healthcare company. Mr. Arena looks forward to deploying the skills gained from his 13-year career to deliver unique insights, investment opportunities, and leadership strategy to investors and founders alike.
Dr. Clement Kairouz MPH is a cosmetic and general dentist practicing in New York City. He is responsible for the development of marketing strategies and growth at Rise Health. He obtained his DDS from NYU College of Dentistry and completed his residency at Yale-New Haven Hospital. Dr. Kairouz also holds an MPH from Icahn School of Medicine at Mount Sinai. He is fluent in English, Arabic, and French, and is the youngest recipient of the American Academy of Cosmetic Dentistry Rising Star Award. Aside from dentistry, Dr. Kairouz is an investor and entrepreneur with interest in oral tech, and is involved in multiple healthcare start-ups.